top of page

Everomus 0.5 mg Tablet

SKU Cadila Healthcare Ltd
Precio original

15,04$

Precio de oferta

12,14$

Everomus 0.5 mg Tablet is a targeted therapy designed to combat certain types of advanced cancers, including those affecting the pancreas, stomach, intestines, and lungs, particularly when surgical options are not viable. This medication is especially effective for postmenopausal women battling advanced hormone receptor-positive, HER2-negative breast cancer. Additionally, it is indicated for adult patients with advanced kidney cancer who have not responded to previous treatments with sunitinib or sorafenib. Everomus works by inhibiting the mTOR pathway, which plays a crucial role in tumor growth and cell proliferation. While it offers significant therapeutic benefits, patients should be aware of potential side effects, including increased risk of infections and alterations in blood sugar levels. Regular monitoring and consultations with healthcare professionals are essential to ensure safe use. Always follow your healthcare provider's instructions regarding dosage and potential interactions with other medications. With its innovative approach, Everomus represents a vital option in the ongoing fight against cancer.

Cantidad

Active Pharmaceutical Ingredient

Everolimus 0.5 mg

Uses

• Everomus 0.5 mg tablet is primarily used in the treatment of postmenopausal women diagnosed with advanced hormone receptor-positive, HER2-negative breast cancer. This medication is often prescribed when previous treatments with aromatase inhibitors like letrozole or anastrozole have not been successful. By working in combination with exemestane, Everomus 0.5 mg tablet helps to inhibit cancer cell growth and progression. This dual approach can provide a more effective management of the disease.
• The use of Everomus 0.5 mg tablet is particularly relevant for patients experiencing specific symptoms associated with advanced breast cancer. Symptoms may include changes in the breast, such as tenderness or alterations in size and shape. By targeting cancer cells, Everomus 0.5 mg tablet can help alleviate some of these distressing symptoms, improving the patient's quality of life. It serves as an important therapeutic option for those with limited treatment alternatives.
• In clinical practice, Everomus 0.5 mg tablet is often utilized to prolong progression-free survival in eligible breast cancer patients. This means that the treatment aims to delay the advancement of cancer and maintain a better overall health status for the patient. Physicians may consider this medication as part of a comprehensive treatment strategy to enhance outcomes for women facing advanced hormone receptor-positive breast cancer. Thus, Everomus 0.5 mg tablet plays a crucial role in modern oncology.
• Everomus 0.5 mg tablet is designed to be used in conjunction with other therapies to maximize its efficacy in treating breast cancer. The combination with exemestane is particularly beneficial after the failure of earlier treatments. This integrated approach not only addresses cancer growth but also helps manage symptoms that significantly impact the patient's daily life. As a result, Everomus 0.5 mg tablet is an essential component of breast cancer management in suitable patients.

Benefits

Everomus 0.5 mg Tablet is indicated to patients dealing with various cancers such as breast cancer, pancreatic cancer, lung cancer, kidney cancer and stomach/ intestinal cancer. Cancer of this type tends to spread quickly in other parts of the body. Everomus 0.5 mg Tablet travels through the bloodstream and effectively destroys cancerous cells and other parts of the body. It works by decreasing the activity of the immune system of the body and prevents the rejection of the transplanted organ. Everomus 0.5 mg works by stopping the action of an abnormal protein that causes the multiplication of cancerous cells. In this way, it stops the spread of cancerous cells. Besides this, it is also effective in people with genetic disorders to treat some types of tumours in the brain or kidneys.

Side Effects

Everomus 0.5 mg Tablet may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.

Most Common Side Effects

• Infection
• Urinary issues
• Hypertension, rise in cholesterol or triglycerides
• Stomach pain, nausea, diarrhoea and/or constipation
• Headache
• Swelling in your legs or feet

Common Side Effects

• Swelling in legs and feet
• Blood in stools and urine
• Burning sensation during urination
• Mouth sores
• Headache
• Tiredness
• Nausea

How To Use

Everomus 0.5 mg Tablet can be taken by mouth with or without food. Swallow the whole tablet with a glass of water. Do not crush, break, or chew the tablets. Take your dose around the same time every day. It is important to make sure you are taking the correct amount of medication every time. Before every dose, check that what you are taking matches what you have been prescribed. If you miss a dose and it has been less than 6 hours since your regular dose time, take it as soon as you remember. If it has been more than 6 hours, skip the dose. Do not take 2 doses at once to make up for a missed dose.

Safety Advice

• Alcohol: It is generally not recommended to drink alcohol while taking Everomus 0.5 mg Tablet. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Everomus 0.5 mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Everomus 0.5 mg is recommended.
• Breastfeeding: It is not recommended to breastfeed while taking Everomus 0.5 mg. Everomus 0.5 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Everomus 0.5 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Everomus 0.5 mg Tablet should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Everomus 0.5 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Everomus 0.5 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Everomus 0.5 mg Tablet may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Everomus 0.5 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Everomus 0.5 mg Tablet may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Everomus 0.5 mg.

bottom of page